SRC:MixSentence, IDs:1CB5D976;485FA936;3AD5669B;AF24C528;430C4AF5;DE757C7F;4F45A2FE;24F2A662;99219F16;FC8C0D50;63624C40;F78D37A9;1F46BF33;4F03F29E;C54A2492;1FADB78C;0ECB4049;04EFBA12;6B520626;E73F66B8;EA15627F;F3096291;39C9A45B;CEC0943E;C0692D6E;48263096;62457DA4
If this is where clinical research is headed, that would be a terrible negative trajectory," he said. Dr. Topol - who drew attention last year with a finding that Celebrex and its competitor, Vioxx, appeared to raise the risk of heart attacks - said the Bextra studies did not include enough patients to justify drawing a broad conclusion. The average age of patients in the study, 23, did not represent the population likely to take the drug, he added. Yet through publication in the leading dental journal, the research helped Bextra's marketers shift attention away from the F.D.A.'s negative findings. Because of confidentiality rules, the F.D.A. cannot release any information about the earlier pain studies that failed to sway regulators. "Even though the study lacked some important proof, the real problem is that in the dental literature, this will be read," Dr. Topol said. "And dentists, who have to deal with trying to prevent or modulate pain, will be impressed." Judy Glova, a spokeswoman for Pharmacia, said the drug company stood behind the design and conclusions of the Scirex studies. Pharmacia was not trying to bypass the regulatory process, she said, adding that the company is in discussions with regulators to have Bextra approved for acute pain. Scirex executives did not return repeated phone calls. Editors at The Journal of the American Dental Association said the Scirex article was reviewed by at least three scientists. One reviewer, Dr. Paul A. Moore, an associate editor of the journal, said the study was "carefully designed and rigorously performed." But Dr. Moore said he would have recommended that the journal reject the paper had he known that Bextra was not approved for acute pain. The Bextra episode is just one example of the changing face of drug research. In the early 1990's, about 75 percent of the drug industry's clinical research dollars went to universities, according to a study by CenterWatch, a company that tracks clinical trials. By 2000, just 34 percent went to academic institutions, while the rest went to investigators working under the direction of either a private research firm like Scirex or a pharmaceutical company. Omnicom says it has no control over Scirex. "We have nothing to do with the design of clinical studies," said Pat Sloan, an Omnicom spokeswoman. Yet when the ad agency paid $20 million for part-ownership of Scirex in 1999, a top Omnicom executive, Thomas L. Harrison, said he expected Scirex's research to produce positive results for drug company clients - results that would help speed new-drug applications, or N.D.A.'s, to the F.D.A. "Our goal," he said, "is to help ensure that all clinical studies and each patient accrued into a study can be assessed to support the N.D.A.
Much of the work of intellectual property lawyers involves offering legal advice to clients on the marketing mechanisms and commercial viability of their product. Get ready for an extraordinary adventure with Jay Berkowitz as your free guide in the ever-changing realm of internet marketing for law firms. Not every site visitor is ready to contact a lawyer-but that doesn’t mean they’re not interested. They don’t. If you cherished this article therefore you would like to acquire more info concerning solicitor advertising kindly visit our page. That’s why they look at your articles, blog postings, honors, activities and presentations. Different ways can be used to maintain and promote intellectual curiosity and currency about arising issues and people profession in an organisation, which includes; asking questions, doing research, formal and informal investigations, reading journals, blog posts, books, articles, and news feeds and also being actively engaged with competitors activities to get information. This is not to say that people don't say critical things about Twitter, but much of this comes from people who haven't really used Twitter or who have dabbled, and who as a result prompt the predictable criticisms in response. Someone criticized Scott's post because Scott does not follow many people on Twitter, and this was the reason why Scott was down on Twitter.
monerica.comStanding out from the competition online can be challenging. There are a variety of social media goals that can be used to measure the ROI of your firm’s social media efforts. Navigating this dynamic landscape requires a firm understanding of innovative strategies that keep your law firm’s brand in the spotlight ? Understanding why your law firm’s video marketing isn’t generating cases reveals the danger of placing great creative production inside a broken, unoptimized website layout. Why? Because a strong social media presence can be key for attracting new clients, and for a field that's over-saturated with complicated jargon, it's essential for building trust! The survey gathered information across four main areas: practice focus, market reputation, client impact, and firm commitment. The voluntary survey requested information on each firm’s fashion-related practice, including confidential client and litigation details that may not be publicly available and are, therefore, not detailed in the ranking. It may be helpful to survey your existing customers and staff to see how they perceive your company, and perform a social media health check. Conceptualising your brand as a person is an extremely helpful exercise to find your social media voice.